Y-mAbs Therapeutics (YMAB) Stock Soars On SERB’s Takeover Offer
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) witnessed a sharp surge in its share price on Tuesday after confirming a definitive acquisition deal with SERB Pharmaceuticals. YMAB stock jumped 103.34%, closing at $8.52. SERB to Acquire Y-mAbs and Lead Oncology Asset The agreement states that SERB would buy Y-mAbs for $8.60 per share, which is 105% more […]